Table 3.
SBTR patients intraoperative and postoperative variables
| GGL (n = 54) | PA (n = 56) | PNET (n = 21) | EP (n = 64) | SUBEP (n = 21) | |
|---|---|---|---|---|---|
| Tumor removal, n (%) | |||||
| Biopsy | 6 (11.1) | 5 (8.9) | 2 (9.5) | 1 (1.6) | 0 |
| Partial | 14 (25.9) | 20 (35.7) | 7 (33.3) | 24 (37.5) | 2 (9.5) |
| Gross total | 34 (63.0) | 31 (55.4) | 12 (57.1) | 39 (60.9) | 19 (90.5) |
| New deficit, n (%) | 6 (11.1) | 11 (19.6) | 7 (33.3) | 22 (34.4) | 4 (19.0) |
| New seizure, n (%) | 0 | 2 (3.6) | 0 | 3 (3.1) | 0 |
| Hematoma, n (%) | 0 | 1 (1.8) | 1 (4.8) | 2 (3.1) | 1 (4.8) |
| Reoperation due to complication, n (%) | 2 (3.7) | 3 (5.4) | 1 (4.8) | 7 (10.9) | 1 (4.8) |
| Infection, n (%) | 1 (1.9) | 5 (8.9) | 1 (4.8) | 10 (15.6) | 1 (4.8) |
| VTE, n/N (%) | 0 | 1 (1.8) | 0 | 5 (7.8) | 0 |
|
Planned oncological treatment, n (%) Missing, n = 7 |
11 (20.8) | 5 (9.3) | 19 (95.0) | 36 (58.1) | 3 (15.0) |
| 30-day mortality, n (%) | 0 | 1 (1.8) | 0 | 2 (3.1) | 0 |
| 1-Year mortality, n (%) | 3 (5.6) | 4 (7.4) | 3 (14.3) | 9 (14.1) | 0 |